SCHEMBL4556536

SCHEMBL4556536

O=C(O)CCCC(CCc1ccc(-c2ccccc2)cc1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 5/20 0.58
MMP12 P39900 4/20 0.54
MMP2 P08253 1/20 0.54
MMP9 P14780 1/20 0.54
MMP13 P45452 1/20 0.54
MMP14 P50281 1/20 0.54
HDAC2 Q92769 2/20 0.49
HDAC3 O15379 1/20 0.49
MAPK1 P28482 1/20 0.49
ADRA1A P35348 1/20 0.49
HDAC4 P56524 1/20 0.49
SLC6A3 Q01959 1/20 0.49
HDAC1 Q13547 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14360024 0.84 HDAC3 (0.54) HDAC2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL14359790 0.81 TBXAS1 (0.54) HDAC2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL14359799 0.81 HDAC3 (0.59) HDAC2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL4558971 0.80 SMN1; SMN2 (0.47) HDAC2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL1651413 0.79 FFAR1 (0.78) FFAR1MMP12MMP2MMP9MMP13
SCHEMBL11699823 0.78 TDP1 (0.63) HDAC2HDAC3HDAC4HDAC1SMN1; SMN2
SCHEMBL1958621 0.77 FFAR1 (0.75) FFAR1MMP12MMP13HDAC2HDAC3
SCHEMBL3146207 0.77 TBXAS1 (0.58) HDAC2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL22971576 0.76 GABBR2 (0.51) HDAC2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL7712810 0.76 CYSLTR2 (0.55) HDAC2HDAC3MAPK1ADRA1AHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080722-A2 CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-07-02 WO disclosed